Join our panel of experts as they discuss the impact of preterm birth on long-term kidney health and what can be done to mitigate risk.

Click here to book now.

HAMRC is pleased to invite you to a special live webinar moderated by:

Alan Liddle, HAMRC Board Member and Executive Director Of Sangui Bio
Alan Liddle has over 30 years' experience in developing and commercialising medical and biological therapeutics and over 30 years’ research & executive management experience in the medical and the biotechnology research sector encompassing immunology and bio-therapeutics for cancer and auto-immune diseases, cardiology, neuroplasticity, the microbiome, regenerative medicine & rehabilitation.

Alan is Executive Director of Sangui Bio a company he cofounded in 2014. Sangui is commercialising its discoveries in the role of red blood cells in immune system activation and regulation. Alan co-founded and was CEO & Director of Immune System Therapeutics Ltd from 2001 to 2011. He was also the Founder, CEO & Director of MicroMedical Industries Limited from 1986. He built the company from a start-up to an ASX listed, international provider of medical monitoring and diagnostic products and a developer of artificial heart technologies. Prior to his biomedical career Alan was a neuropsychologist researcher at the University of Sydney specialising in rehabilitation of patients following traumatic brain injuries.

Featuring our expert panel:

Dr. Alex Combes, Head, Combes Laboratory, Monash Biomedicine Discovery Institute

Dr Alex Combes and his team use single cell sequencing, advanced imaging and molecular genetics to investigate how the kidney forms during development and how disruption of developmental programs can cause or contribute to disease.

Since 2015, Dr Combes has been a recipient of multiple research grants in excess of $2.4 million. He has published over 40 research papers with several highly cited publications on nephron progenitor regulation. He leads a group of skilled scientists as head of the Combes Laboratory at the Monash Biomedicine Discovery Institute, Monash University in Melbourne.

Andrea Henry, Nephrology Nurse and Co-Founder, Miracle Babies

Andrea Hendry's nursing career includes 10 years as a Nephrology Nurse specializing in adult and paediatric acute and chronic haemodialysis patients in Orange County California USA and Sydney Australia. She is the co-founder of the Miracle Babies Foundation, Australia’s leading organisation supporting premature and sick newborns, their families and the hospitals that care for them. She also co-founded the Nurture Program, Australia’s only comprehensive parent to parent support program to assist parents through a threatened pregnancy, during the time spent in a Neonatal Intensive Care Unit (NICU) or Special Care Nursery (SCN) and the transition to home and beyond.

Andrea has two sons who were born at 28 weeks and 30 weeks respectively. She is an ardent voice for awareness of the ongoing needs and problems of premature and sick newborns.

Associate Professor Shilpanjali Jesudason staff specialist Nephrologist and Chair of Clinical Research, Royal Adelaide Hospital

A/Prof Jesudason (MBBS, PhD, FRACP; née Prasad) is a Staff Specialist Nephrologist and Chair of the Clinical Research Group at the Royal Adelaide Hospital’s Central Northern Adelaide Renal and Transplant Service (CNARTS), the former National Clinical Director of Kidney Health Australia, the peak patient organisation for kidney disease and Associate Professor, University of Adelaide.

A/Prof Jesudason is an expert in CKD and pregnancy in patients with CKD. She has built substantial research capacity and grown the research workforce within CNARTS. In 2015, she established the CNARTS Clinical Research Group, conducting patient-centred studies to immediately influence clinical care through evidence-based practice changes, with a focus on the transition to dialysis; psychological resilience and coping; patient-reported outcome measures and symptom burden; community partnerships to inform kidney care for Indigenous patients. She is recognised as an expert on Parenthood in kidney patients and 2012, she established the only Obstetric Nephrology Service in SA . Her research has influenced models of care for women with CKD.

Dr. Oded Volovelsky, Head of Paediatric Nephrology Services, Hadassah-Hebrew University Medical Centre, Israel

Dr Volovelsky is the head of Paediatric Nephrology Service at Hadassah-Hebrew University Medical Centre in Israel. He led a team of high-level clinical staff to establish a new paediatric nephrology unit including a dialysis unit and kidney transplantation program. He is also a co-director for the Tuberous Sclerosis Multidisciplinary Clinic. Apart from his memberships on several Israeli and International prestigious scientific societies, Dr Volovelsky is a research associate of the Wohl Institute for Translational Medical Research, and a member of numerous institutional and academic committees.

Dr Volovelsky has diverse experience in different fields of the molecular biology of kidney diseases. His main research interest is internal and external mechanisms affecting kidney development in utero. Oded believes that children at birth should be given the opportunity to reduce their chances of developing kidney disease later in life.